drugset / Trial / NCT04884503
Evaluation of the Effectiveness of the Selected Method of Treatment of Primary Burning Mouth Syndrome
RandomizedCrossoverQuadruple-blindTreatment
Summary
The burning mouth syndrome (BMS) is a chronic pain syndrome of the oral mucosa. Feels like experiencing a burning sensation, pain, stinging, or numbness in the mouth along with a feeling of dryness, paraesthesia, taste disturbance or hypersensitivity.The complaints are usually bilateral, of moderate intensity, they persist for a minimum of 4-6 months and concern the clinically unchanged membrane mucous.The psychiatric aspect of BMS is very important. The presence of BMS has been shown to be associated with depression, increased anxiety levels, hypochondria, and carcinophobia and emotional instability
Timeline
- Start
- 2019-01-12
- Primary completion
- 2020-04-03
- Completion
- 2020-09-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clonazepam | Small molecule | 1 mg | Oral |